Oppenheimer Asset Management Inc. Increases Position in Synopsys, Inc. $SNPS

Oppenheimer Asset Management Inc. lifted its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 2.3% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 30,243 shares of the semiconductor company’s stock after buying an additional 683 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Synopsys were worth $15,505,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the company. Nuveen LLC purchased a new position in Synopsys during the first quarter worth approximately $341,480,000. Pictet Asset Management Holding SA raised its stake in Synopsys by 38.3% during the first quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company’s stock worth $1,043,518,000 after purchasing an additional 673,837 shares during the period. Generation Investment Management LLP purchased a new position in Synopsys during the first quarter worth approximately $240,491,000. Vanguard Group Inc. raised its stake in Synopsys by 2.4% during the first quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock worth $6,359,747,000 after purchasing an additional 346,994 shares during the period. Finally, Alliancebernstein L.P. raised its stake in Synopsys by 22.2% during the first quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock worth $739,857,000 after purchasing an additional 313,218 shares during the period. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. BNP Paribas assumed coverage on shares of Synopsys in a research note on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price target on the stock. KeyCorp cut their price target on shares of Synopsys from $660.00 to $590.00 and set an “overweight” rating on the stock in a research note on Wednesday, September 10th. Bank of America reaffirmed an “underperform” rating and set a $525.00 price target (down previously from $625.00) on shares of Synopsys in a research note on Wednesday, September 10th. Wells Fargo & Company dropped their price objective on shares of Synopsys from $630.00 to $550.00 and set an “equal weight” rating for the company in a research report on Wednesday, September 10th. Finally, Robert W. Baird reissued a “neutral” rating and issued a $535.00 price objective (down previously from $670.00) on shares of Synopsys in a research report on Wednesday, September 10th. Ten research analysts have rated the stock with a Buy rating, five have given a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $569.67.

Insider Activity

In related news, CFO Shelagh Glaser sold 3,655 shares of the firm’s stock in a transaction on Friday, September 5th. The shares were sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the completion of the sale, the chief financial officer directly owned 15,317 shares of the company’s stock, valued at approximately $9,339,847.09. This trade represents a 19.27% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Sassine Ghazi sold 11,366 shares of the firm’s stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the sale, the chief executive officer directly owned 71,615 shares of the company’s stock, valued at approximately $42,181,951.15. The trade was a 13.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 30,894 shares of company stock valued at $16,760,783 in the last 90 days. Company insiders own 0.62% of the company’s stock.

Synopsys Price Performance

Synopsys stock opened at $464.18 on Monday. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The firm has a fifty day moving average of $509.56 and a 200-day moving average of $513.66. The firm has a market capitalization of $86.22 billion, a P/E ratio of 36.43, a PEG ratio of 5.11 and a beta of 1.10. The company has a quick ratio of 1.51, a current ratio of 1.62 and a debt-to-equity ratio of 0.52.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing analysts’ consensus estimates of $3.75 by ($1.45). The firm had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.77 billion. Synopsys had a net margin of 31.04% and a return on equity of 10.82%. Synopsys’s revenue for the quarter was up 14.0% on a year-over-year basis. During the same period in the previous year, the business posted $3.43 earnings per share. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. As a group, analysts predict that Synopsys, Inc. will post 10.64 EPS for the current year.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.